(Adds analyst comments in paragraph 5, 9 and 10) By Pragyan Kalita Sept 25 (Reuters) – Shares of ADARx Pharmaceuticals rose 30% above their initial public offering price on Friday after the late-stage
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
SINGAPORE, Nov 11 (Reuters) - A former executive of Chinese refiner Hengli Petrochemical's defunct Asia…
VIDEO SHOWS: HIGHLIGHTS FROM WTA FINALS - WINS FOR LINDA NOSKOVA AND JESSICA PEGULA COMPLETE…
By Kanishka Singh WASHINGTON, Nov 10 (Reuters) - Republican US Senator Kevin Cramer from the…
By Kanishka Singh WASHINGTON, Nov 10 (Reuters) - Republican US Senator Kevin Cramer from the…
Nov 10 (Reuters) - Neuronetics Inc: * NEURONETICS ANNOUNCES PRICING OF $30 MILLION UNDERWRITTEN PUBLIC…
VIDEO SHOWS: HIGHLIGHTS FROM WTA FINALS - WINS FOR LINDA NOSKOVA AND JESSICA PEGULA COMPLETE…